FDA to speed up approvals of generic biologic medicines
Digest more
Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.
👋 Welcome to 5 Things PM! After a flurry of lawsuits, Character.AI will no longer let teens talk with its chatbots. Instead ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
The blockbuster Sanofi and Regeneron Pharmaceuticals drug Dupixent, already commercialized in several skin and lung disorders, has expanded its FDA-approval to chronic obstructive pulmonary disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback